Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals
Author(s) -
Barbara Kollerits,
Claudia Lamina,
Cornelia Huth,
Pedro MarquesVidal,
Stefan Kiechl,
Ilkka Seppälä,
Jackie A. Cooper,
Steven C. Hunt,
Christa Meisinger,
Christian Herder,
Ludmilla Kedenko,
Johann Willeit,
Barbara Thorand,
Doreen Dähnhardt,
Doris Stöckl,
Karin Willeit,
Michael Roden,
Wolfgang Rathmann,
Bernhard Paulweber,
Annette Peters,
Mika Kähönen,
Terho Lehtimäki,
Olli T. Raitakari,
Steve E. Humphries,
Péter Vollenweider,
Hans Dieplinger,
Florian Kronenberg
Publication year - 2017
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc17-0201
Subject(s) - medicine , prediabetes , type 2 diabetes , diabetes mellitus , incidence (geometry) , odds ratio , prospective cohort study , cohort study , gastroenterology , endocrinology , physics , optics
The human vitamin E-binding glycoprotein afamin is primarily expressed in the liver and has been associated with prevalent and incident metabolic syndrome. These data were in line with observations in transgenic mice. We thus investigated whether afamin concentrations are associated with prediabetes, type 2 diabetes, and insulin resistance (IR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom